Page last updated: 2024-12-07

azacycloheptane-2,2-diphosphonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azacycloheptane-2,2-diphosphonate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92084
SCHEMBL ID285385
MeSH IDM0099845

Synonyms (16)

Synonym
(hexahydro-2h-azepin-2-ylidene)bis(phosphonic) acid
56269-44-4
azepane-2,2-diylbis(phosphonic acid)
(2-phosphonoazepan-2-yl)phosphonic acid
unii-k4rp0644xf
azacycloheptane-2,2-diphosphonate
k4rp0644xf ,
einecs 260-083-6
SCHEMBL285385
W-111112
azacyloheptane diphosphonic acid
phosphonic acid, (hexahydro-2h-azepin-2-ylidene)bis-
turpinal-ahp
azacycloheptane-2,2-diphosphonic acid
DTXSID20971703
Q27281962

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" APDP rapidly transformed into DHAP in vivo and in vitro, indicating that there were no significant differences in the values of mean residence time in vivo [MRT (0‑t)], half‑life [t1/2], oral bioavailability and antiplatelet aggregation activity in vivo and in vitro between the two agents."( Synthesis, oral bioavailability evaluation and antiplatelet aggregation activity of three derivatives of 3,4‑dihydroxyacetophenone.
Duan, Y; Lv, Y; Qu, M; Sun, N; Wang, M; Wei, L, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.11 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]